Cyrus

Vilya Appoints Cyrus Harmon, Ph.D., as Chief Executive Officer

Retrieved on: 
Tuesday, October 17, 2023
Health, Technology, Health Technology, Nanotechnology, Artificial Intelligence, Biotechnology, Vitae, Cyrus, IPD, Scripps Research, Drug development, Machine learning, Bristol Myers Squibb, Berkeley, Coronavirus Scientific Advisory Board, University, Artificial intelligence, Therapy, Affymetrix, Protein, Molecular biology, Cell biology, Drug discovery, ARCH Venture Partners, Harmon, Pharmaceutical industry, Vilya, Muller's morphs

VILYA, Inc. (Vilya), a biotechnology company creating a new class of medicines that precisely target disease biology, today announced the appointment of Cyrus Harmon, Ph.D., as its Chief Executive Officer.

Key Points: 
  • VILYA, Inc. (Vilya), a biotechnology company creating a new class of medicines that precisely target disease biology, today announced the appointment of Cyrus Harmon, Ph.D., as its Chief Executive Officer.
  • “I am very excited to join the phenomenal team at Vilya developing new macrocycle drugs,” said Harmon.
  • Previously, Harmon co-founded and served as CEO of Olema Oncology, a company focused on women’s cancers, before transitioning to the role of Chief Research Officer.
  • Harmon joins Katerina Leftheris, Ph.D., Vilya’s Chief Scientific Officer on the company’s leadership team.

Medical Solutions launches new ciro technology platform to put users in the driver's seat

Retrieved on: 
Monday, August 14, 2023
Nursing, Rising Medical Solutions, PRN, Hospital, Patient, Cyrus, Ecosystem, Ciro, Nightclub

The ultimate toolbox for users, ciro (pronounced 'seer-roh') makes working with Medical Solutions simpler, faster, and more rewarding than ever.

Key Points: 
  • The ultimate toolbox for users, ciro (pronounced 'seer-roh') makes working with Medical Solutions simpler, faster, and more rewarding than ever.
  • Another product within the platform, ciro talent management offers a single place for everything clients need — from managing requisitions to scheduling, compliance, and billing; it is just one dynamic piece of a larger ecosystem of talent solutions Medical Solutions provides.
  • Additionally, ciro affiliate empowers affiliates to effectively collaborate and communicate with Medical Solutions to simplify and enhance workflows, fostering a cohesive and efficient healthcare network.
  • Through ciro, Medical Solutions provides a seamless, curated experience to put users in the driver's seat.

Pheon Therapeutics Appoints Industry Veteran Cyrus Mozayeni, MD as Chief Executive Officer

Retrieved on: 
Tuesday, July 25, 2023
Business development, IPO, University, SVKM's NMIMS, Therapy, Atlas Venture, MBA, Kellogg School, History, Sale, CAR, Virginia School for Girls, MD, Patient, CBO, Brown University, Broad arrow, Wilderness medicine, Conjugation, ADC, Cyrus, University of Virginia School of Medicine, Spacecraft, Bluebird bio, Antibody-drug conjugate, Northwestern University, Pharmaceutical industry, Novartis

LONDON and CAMBRIDGE, Mass., July 25, 2023 /PRNewswire/ -- Pheon Therapeutics (Pheon), a leading Antibody-Drug Conjugate (ADC) company developing next generation ADCs for a wide range of hard-to-treat cancers, today announced the appointment of Cyrus Mozayeni, MD as Chief Executive Officer.

Key Points: 
  • LONDON and CAMBRIDGE, Mass., July 25, 2023 /PRNewswire/ -- Pheon Therapeutics (Pheon), a leading Antibody-Drug Conjugate (ADC) company developing next generation ADCs for a wide range of hard-to-treat cancers, today announced the appointment of Cyrus Mozayeni, MD as Chief Executive Officer.
  • Dr. Mozayeni joins Pheon with over 20 years of experience in the biotechnology industry and a strong history of driving strategic business growth.
  • Cyrus Mozayeni, Chief Executive Officer of Pheon Therapeutics, said: "Pheon has a uniquely differentiated and preclinically validated approach to discovering and developing ADC therapeutics.
  • Jeff Albers, Chairman of Pheon Therapeutics, commented: "Cyrus' extensive experience and a proven track record, make him the ideal person to guide Pheon through our next stage of Company growth.

Pheon Therapeutics Appoints Industry Veteran Cyrus Mozayeni, MD as Chief Executive Officer

Retrieved on: 
Tuesday, July 25, 2023
Business development, IPO, University, SVKM's NMIMS, Therapy, Atlas Venture, MBA, Kellogg School, History, Sale, CAR, Virginia School for Girls, MD, Patient, CBO, Brown University, Broad arrow, Wilderness medicine, Conjugation, ADC, Cyrus, University of Virginia School of Medicine, Spacecraft, Bluebird bio, Antibody-drug conjugate, Northwestern University, Pharmaceutical industry, Novartis

LONDON and CAMBRIDGE, Mass., July 25, 2023 /PRNewswire/ -- Pheon Therapeutics (Pheon), a leading Antibody-Drug Conjugate (ADC) company developing next generation ADCs for a wide range of hard-to-treat cancers, today announced the appointment of Cyrus Mozayeni, MD as Chief Executive Officer.

Key Points: 
  • LONDON and CAMBRIDGE, Mass., July 25, 2023 /PRNewswire/ -- Pheon Therapeutics (Pheon), a leading Antibody-Drug Conjugate (ADC) company developing next generation ADCs for a wide range of hard-to-treat cancers, today announced the appointment of Cyrus Mozayeni, MD as Chief Executive Officer.
  • Dr. Mozayeni joins Pheon with over 20 years of experience in the biotechnology industry and a strong history of driving strategic business growth.
  • Cyrus Mozayeni, Chief Executive Officer of Pheon Therapeutics, said: "Pheon has a uniquely differentiated and preclinically validated approach to discovering and developing ADC therapeutics.
  • Jeff Albers, Chairman of Pheon Therapeutics, commented: "Cyrus' extensive experience and a proven track record, make him the ideal person to guide Pheon through our next stage of Company growth.

Miley Cyrus & Disney Reunite for the Disney+ Original Special Event: “Miley Cyrus - Endless Summer Vacation (Backyard Sessions)”

Retrieved on: 
Friday, March 3, 2023
Film & Motion Pictures, TV and Radio, Content Marketing, Music, Communications, Celebrity, Events, Concerts, Entertainment, Crush Management, Disney Branded Television, Tish Cyrus, Endless Summer Vacation, Photography, The Walt Disney Company, Television, RadicalMedia, Backyard Sessions, PST, Columbia Records, Multimedia, Cyrus, Miley Cyrus

Disney+ will celebrate multiplatinum-selling recording artist Miley Cyrus’ highly anticipated eighth studio album Endless Summer Vacation with an original special event, “Miley Cyrus ‒ Endless Summer Vacation (Backyard Sessions).” Miley Cyrus serves as executive producer on the music-focused performance special from Disney Branded Television will showcase new music from Endless Summer Vacation, including “Flowers,” which has been No.

Key Points: 
  • Disney+ will celebrate multiplatinum-selling recording artist Miley Cyrus’ highly anticipated eighth studio album Endless Summer Vacation with an original special event, “Miley Cyrus ‒ Endless Summer Vacation (Backyard Sessions).” Miley Cyrus serves as executive producer on the music-focused performance special from Disney Branded Television will showcase new music from Endless Summer Vacation, including “Flowers,” which has been No.
  • Produced by Miley Cyrus, the award-winning creative production company RadicalMedia, HopeTown Entertainment, Crush Management and Columbia Records, “Miley Cyrus ‒ Endless Summer Vacation (Backyard Sessions)” is set to premiere on Friday, March 10, at 1 p.m. EST/10 a.m. PST on Disney+.
  • “Miley Cyrus ‒ Endless Summer Vacation (Backyard Sessions)” serves as a continuation.
  • “Miley Cyrus – Endless Summer Vacation (Backyard Sessions)” is produced by RadicalMedia, Miley Cyrus, HopeTown Entertainment, Crush Management and Columbia Records.

Greenberg Traurig Is Recognized as "Leading Light 2022" for its Outstanding Pro Bono Work

Retrieved on: 
Friday, February 3, 2023
Culture, Woman, Greenberg Traurig, Institutionalisation, MEXICO, LLP, Cyrus, Refugee, Drug

MEXICO CITY, Feb. 2, 2023 /PRNewswire-PRWeb/ -- The Mexico City office of global law firm Greenberg Traurig, LLP was recognized as a Pro Bono Leading Light 2022 firm by the English publication Latin Lawyer and The Cyrus R. Vance Center for its outstanding work and pro bono efforts during 2022.

Key Points: 
  • The Mexico City office of global law firm Greenberg Traurig, LLP was recognized as a Pro Bono Leading Light 2022 firm by the English publication Latin Lawyer and The Cyrus R. Vance Center for its outstanding work and pro bono efforts during 2022.
  • MEXICO CITY, Feb. 2, 2023 /PRNewswire-PRWeb/ -- The Mexico City office of global law firm Greenberg Traurig, LLP was recognized as a Pro Bono Leading Light 2022 firm by the English publication Latin Lawyer and The Cyrus R. Vance Center for its outstanding work and pro bono efforts during 2022.
  • "We are very pleased to be recognized for our continued pro bono work in Mexico.
  • Greenberg Traurig has established a formal practice area, with processes, a vision and a mission, which has resulted in achieving 5,000 pro bono hours per year.

Hyperion Completes Acquisition of A Plus Tree

Retrieved on: 
Tuesday, November 8, 2022
Acquisition, Cyrus, Growth, Company, Partner, Plus, McGuireWoods, Love, Hyperion, Culture, Leadership, Family, A+, CEO, Financial services

LOS ANGELES, Nov. 8, 2022 /PRNewswire/ -- Hyperion Capital Partners LLC ("Hyperion") today announced it has completed the acquisition of A Plus Tree, Inc. ("A Plus" or the "Company") from Paula Tibbets and family.

Key Points: 
  • LOS ANGELES, Nov. 8, 2022 /PRNewswire/ -- Hyperion Capital Partners LLC ("Hyperion") today announced it has completed the acquisition of A Plus Tree, Inc. ("A Plus" or the "Company") from Paula Tibbets and family.
  • A Plus is a leading provider of tree care services for commercial and residential clients located across the West Coast.
  • Headquartered in Vallejo, California, A Plus provides specialized services to property owners and managers, including tree trimming, pruning, and removal; plant and tree healthcare; and arborist consulting.
  • Headquartered in Vallejo, California, A Plus Tree is a leading provider of tree care services for commercial and residential clients.

Land Topography Corporation Becomes a California Licensed Land Surveyor

Retrieved on: 
Wednesday, September 28, 2022
COVID-19, ALTA, Cyrus, Engineering, Growth, Workload, GIS, RTK, Surveying

Summary: Land Topography Corporation was established as an engineering consultant firm in Los Angeles. Recently, the company announced the expansion of its service after becoming a California-licensed land surveyor.

Key Points: 
  • Furthermore, Land Topography Corporation has been in the field since 2014.
  • The company has also split its surveying operations into four different departments, each offering specific services in residential, commercial, land use, or building construction.
  • In addition to that, Land Topography Corporation has progressed after the expansion.
  • The CEO of Land Topography Corporation, Cyrus Azarmy, is an artist and engineering consultant.

TeraWatt Raises Over $1 Billion to Scale Commercial EV Charging Centers Across America

Retrieved on: 
Tuesday, September 13, 2022
Professional Services, Automotive, EV, Electric Vehicles, Environment, Green Technology, Finance, Fleet Management, Light, Carbon, Organization, Company, Cyrus, CEO, Solution, Transport, Watt, EV, Key frame, SEC, Renewable energy

TeraWatt Infrastructure (TeraWatt or the Company), a company powering electrified fleets with the most reliable network of charging centers, today announced that it has secured more than $1 billion of institutional capital to support the buildout of its fleet-focused charging centers and operations.

Key Points: 
  • TeraWatt Infrastructure (TeraWatt or the Company), a company powering electrified fleets with the most reliable network of charging centers, today announced that it has secured more than $1 billion of institutional capital to support the buildout of its fleet-focused charging centers and operations.
  • The Company acquires properties in locations strategically relevant to fleets and develops the energy and charging infrastructure necessary to operate at scale.
  • TeraWatts Charging Centers provide reservable and reliable space as well as high-power charging levels at optimal locations for commercial electric vehicle fleets.
  • The company designs, operates and owns electric vehicle charging centers for fleet operations combining property assets with energy and charging expertise.

Academic, Industry Leaders Form OpenFold AI Research Consortium to Develop Open Source Software Tools To Understand Biological Systems and Discover New Medicines

Retrieved on: 
Tuesday, June 28, 2022
Biotechnology, Technology, Health, Philanthropy, Pharmaceutical, Other Science, Research, Software, Artificial Intelligence, Foundation, Science, Registry, CAMEO, Artificial intelligence, CEO, Biology, Research, OpenAI, Linux, Industry average, Â, Google, Industry, Structural biology, Continuity, The Apache Software Foundation, Technology, University, Organization, Cyrus, Software, Amazon Web Services, AWS, DeepMind, Preprint, VP, Associate, Twitter, Apache, Computation, Multimedia, Drug discovery, Pharmaceutical industry, Medical device

OpenFold is a project of the Open Molecular Software Foundation (OMSF), a non-profit organization advancing molecular sciences by building communities for open source research software development.

Key Points: 
  • OpenFold is a project of the Open Molecular Software Foundation (OMSF), a non-profit organization advancing molecular sciences by building communities for open source research software development.
  • The OpenFold consortium is modeled after pre-competitive technology industry open source consortia such as Linux and OpenAI .
  • The software is available under a free and open source license from The Apache Software Foundation at https://github.com/aqlaboratory/openfold .
  • OpenFold is a non-profit artificial intelligence (AI) research consortium of academic and industry partners whose goal is to develop free and open-source software tools for biology and drug discovery, hosted as a project of the Open Molecular Software Foundation.